Lysosomal diseases: understanding their origin and impact

Lysosomal diseases are among the least known rare diseases to the general public, yet they affect thousands of families around the world. In France, more than 3,000 cases have been recorded according to the association Vaincre les maladies lysosomales (Defeating Lysosomal Diseases). Among them, Sanfilippo disease is one of the most studied. Understanding what these diseases are, not only helps us learn more about how they work, but also enables us to better support research and the families affected.

Lysosomes: the “recycling centers” of cells

To understand lysosomal diseases, we must first understand what lysosomes are.

Each cell in our body contains different organelles, which are like small specialized factories. Lysosomes play a key role in cleaning and recycling cell waste.

Think of them as tiny “bags” filled with enzymes that can break down large molecules that have become useless or damaged. Once the waste has been processed, the cell can reuse the useful elements and get rid of the harmful ones.

When everything is working properly, this process is invisible and vital. But when one link in the chain is defective, the consequences can be serious.

What is a lysosomal disease?

A lysosomal disease occurs when a specific enzyme in the lysosome does not function properly or is completely absent. As a result, the cell is unable to break down certain substances.

These substances then accumulate in the lysosomes, causing cellular congestion. Gradually, the cells, and then the organs, lose their ability to function properly.

There are more than 50 identified types of lysosomal diseases, each caused by a different enzyme or a defect in the transport of molecules. They often affect several organs, as well as the central nervous system, which explains the severity of their symptoms.

Causes and transmission of lysosomal diseases

Lysosomal diseases are genetic. This means that the abnormality is located in the DNA, in a gene that contains the instructions for making a specific enzyme.

Most are inherited in an autosomal recessive pattern:

  • A child must receive two defective copies of the gene (one from each parent) to develop the disease.
  • Parents are usually healthy carriers: they have no symptoms, but can pass on the defective gene.

This transmission makes prevention difficult, as parents are often unaware that they are carriers until their child is diagnosed.

Among the best known are:

  • Sanfilippo syndrome (mucopolysaccharidosis type III)
  • Gaucher disease
  • Fabry disease
  • Pompe disease
  • Hurler disease

These diseases are distinguished by the type of molecule that accumulates and the symptoms observed. For example, Sanfilippo syndrome causes an accumulation of glycosaminoglycans in the brain and other tissues, leading to progressive neurological decline.

Common symptoms of lysosomal diseases

Symptoms vary greatly from one disease to another, but often include:

  • Developmental delay
  • Language disorders
  • Progressive loss of certain acquired abilities
  • Damage to internal organs (liver, spleen, heart)
  • Motor disorders and joint stiffness
  • Breathing difficulties
  • In some cases, behavioral disorders

In Sanfilippo syndrome, the first signs often appear between the ages of 2 and 6, with sleep disorders, hyperactivity, and language delay, followed by a gradual loss of acquired skills.

Diagnosis: often a long process

Diagnosing a lysosomal disease can take years. The first symptoms are sometimes subtle or confused with other disorders (autism, behavioral disorders, global developmental delay).

The stages of diagnosis generally include:

  1. Urine analysis: detection of abnormal substances.
  2. Blood test: measurement of enzyme activity.
  3. Genetic testing: confirmation of the mutation.

Early diagnosis is essential in order to provide appropriate follow-up and, in some cases, to begin treatment before the damage becomes irreversible.

treatments and advances in research

There is still no cure for most lysosomal diseases, but research is progressing rapidly. The main therapeutic approaches include:

  • Enzyme replacement therapy: providing the patient with the missing enzyme (already used for Gaucher disease and Pompe disease).
  • Gene therapy: correcting the defective gene so that the body can produce the enzyme itself.
  • Small molecules: facilitating enzyme function or reducing the production of the accumulated substance.
  • Supportive care: physical therapy, speech therapy, educational support, psychological support.

For Sanfilippo syndrome, several clinical trials of gene therapy are underway around the world.

Living with a lysosomal disease

Living with a lysosomal disease is a daily challenge, both for the person affected and for their family.

Medical support must be multidisciplinary: neurologists, geneticists, speech therapists, psychologists, etc.

Associations play an essential role by:

  • Offering moral and practical support
  • Helping with access to financial and medical assistance
  • Funding research
  • Raising awareness among the general public

For Sanfilippo, associations such as Vaincre Sanfilippo, Les Petits Guerriers, and international foundations work both to support families and accelerate research.

Why raise awareness about lysosomal diseases?

Although rare, lysosomal diseases collectively affect thousands of people. The more informed the public is, the more research can advance through:

  • Mobilization around donation campaigns
  • Participation in clinical trials
  • Pressure to fund public and private programs

By better understanding what lysosomes are and their vital role, we realize that these diseases are not mere “medical curiosities,” but real public health emergencies.

conclusion

Lysosomal diseases, such as Sanfilippo syndrome, are complex and still poorly understood. They begin at the microscopic level—in the lysosomes—but have major consequences on the lives of patients and their loved ones.

Research is advancing, driven by the passion of scientists, the determination of families, and the solidarity of associations. Informing, sharing, and supporting are simple but essential actions in the fight against these rare diseases.

Read also:

Partager

Nos autres contenus

Donations and patronage: pillars of financing the general interest

Donations and patronage: pillars of financing the general interest

In a context marked by pressure on public budgets and the rise of hybrid models in the social economy, donations from individuals and corporate patron represent essential financial resources for public interest structures. In France, they represented €5.4 billion and...

UN Ocean Summit: Protecting the Seabed

UN Ocean Summit: Protecting the Seabed

From June 9 to 13, 2025, the city of Nice will become the global epicenter of marine governance. It will host the third United Nations Conference on the Ocean. Co-organized by France and Costa Rica, this event will bring together more than 70 heads of state, 4,000...

Heatwaves: Cities adapt to the heat, wildlife suffocates

Heatwaves: Cities adapt to the heat, wildlife suffocates

With increasingly extreme temperatures, heatwaves are becoming a summer norm in France. Cities and ecosystems are trying to adjust, often urgently. There is no longer any doubt: heatwaves are no longer exceptional episodes. They have become regular occurrences,...